AmyM.SMillerMDFACOG

PubMed

• Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
  Bachanova, V.,Marks, D. I.,Zhang, M. J.,Wang, H.,de Lima, M.,Aljurf, M. D.,Arellano, M.,Artz, A. S.,Bacher, U.,Cahn, J. Y.,Chen, Y. B.,Copelan, E. A.,Drobyski, W. R.,G...> ;Leukemia. 2013 Aug 30
• Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study.
  Waubant E, Pelletier D, Mass M, Cohen JA, Kita M, Cross A, Bar-Or A, Vollmer T, Racke M, Stüve O, Schwid S, Goodman A, Kachuck N, Preiningerova J, Weinstock-Guttman B,...> ;Neurology. 2012-04-10
• GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
  Goodman, A. D.,Rossman, H.,Bar-Or, A.,Miller, A.,Miller, D. H.,Schmierer, K.,Lublin, F.,Khan, O.,Bormann, N. M.,Yang, M.,Panzara, M. A.,Sandrock, A. W.> ;Neurology. 2009 Mar 3
• Intravenous immunoglobulin treatment in multiple sclerosis.
  Gadoth N, Melamed E, Miller A, Steiner I, Abramsky O> ;Neurology. 1999-01-01
• Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
  Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R> ;Neurology. 1995-11-01
• Inner-city birth rates following enactment of the Minnesota Parental Notification Law.
  Rogers, J.L., Miller, A.M.> ;Law Hum Behav. 1993 Feb
• Clinical trial design in multiple sclerosis therapy.
  Weiss W, Bornstein MB, Miller A, Slagle S> ;Neurology. 1988-07-01
• Join now to see all